Blog

Aptorum Group Limited (NASDAQ:APM), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced President and Executive

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that Brian M. Culley

NICE (Nasdaq: NICE) today announced the launch of NEVA@home, helping organizations make it easy for their employees to provide continued service excellence even when working remotely. Additionally

Today PulteGroup announced that its Built to Honor® program was named a 2020 Hearthstone Award Winner. This is the second time the program has been recognized by Hearthstone after receiving a

Cushman & Wakefield plc (NYSE: CWK) (“Cushman & Wakefield”) today announced that its indirect wholly owned subsidiary, Cushman & Wakefield U.S. Borrower, LLC (the “Issuer”), plans to conduct an

Perion Network Ltd. (NASDAQ:PERI) a global technology company that delivers its Synchronized Digital Branding solution across the three main pillars of digital advertising - ad search, social media

Regis Corporation (NYSE: RGS), a leader in the haircare industry, whose primary business is franchising, owning, and operating technology enabled hair salons, announced today that it successfully

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today the publication of its Reasoned Position Statement in response to the Offer Document published by Thermo Fisher Scientific

Regulatory News:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200517005052/en/

Vifor Fresenius Medical Care Renal Pharma (VFMCRP)

Spectra7 Microsystems Inc. (TSX:SEV) (“Spectra7” or the “Company”), a leading provider of high-performance analog semiconductor products for broadband connectivity markets, announced today that the

The Board of Directors of Albany International Corp. (NYSE: AIN) today declared a quarterly dividend of $0.19 per share on the Company’s Class A and Class B Common Stock, payable July 10, 2020, to

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that Peter Greenleaf, President and Chief Executive Officer of Aurinia, will participate in a fireside chat

EPR Properties (NYSE:EPR) announced today that due to the ongoing public health issues arising from the COVID-19 pandemic and to support the health and well-being of its shareholders, it is

Clovis Oncology, Inc. (NASDAQ: CLVS), announced today that the U.S. Food and Drug Administration (FDA) approved Rubraca^® (rucaparib) tablets for the treatment of adult patients with a deleterious B

On May 6, 2020, BlackRock Capital Investment Corporation (the “Company”) announced the declaration by its Board of Directors of a dividend for the second quarter of 2020 at a rate of $0.10 per

The AGM approved the proposal to appoint Lard Friese as member of the Executive Board for a term of four years. Lard Friese succeeds Alex Wynaendts as CEO of Aegon.

Shareholders also approved

American International Group, Inc. (NYSE: AIG) today announced its virtual participation in the following upcoming financial conferences:

Sabra Purtill, Senior Vice President, Deputy Chief

TMAC Resources Inc. (TSX: TMR) (“TMAC” or the “Company”) is pleased to announce that the previously announced non-brokered private placement (the “Private Placement”) with Shandong Gold Mining Co

Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator in automotive vision systems, announced today that it has joined the All Weather Autonomous Real logistics operations and

Trex Company, Inc. (NYSE:TREX), the world’s number-one brand of decking and railing and leader in high-performance, low-maintenance outdoor living products, and a leading national provider of

Today, the Board of Directors of Reply S.p.A. [MTA, STAR: REY] approved the results as at 31 March 2020.

Since the beginning of the year, the Group has recorded a consolidated turnover amounting

Pfizer Inc. (NYSE: PFE) today announced updated Phase 1b clinical data on PF-06939926, an investigational gene therapy being developed to treat Duchenne muscular dystrophy (DMD). The preliminary

IMV Inc. (the “Company” or “IMV”) (TSX:IMV; NASDAQ:IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat, today announced financial

Regulatory News:

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and BioInvent International AB (“BioInvent”)